Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
An update from Zymeworks (ZYME) is now available.
Zymeworks Inc. has announced a Share Repurchase Program to buy back up to $60 million of its common stock, projecting that its cash on hand and expected regulatory payments will fund operations well into the second half of 2027. However, these projections are forward-looking statements subject to risks and uncertainties, and actual results may vary. The company emphasizes that these statements are based on current expectations and may change over time.
For detailed information about ZYME stock, go to TipRanks’ Stock Analysis page.
